Inflammation, Obesity, and the Metabolic Syndrome

Abstract

Adipose tissue expresses cytokines which inhibit insulin signalling pathways. Obesity also results in impairment of endothelium-dependent vasodilatation to insulin. We have previously suggested that adipocytokines might contribute to the coexistence of insulin resistance and endothelial dysfunction. However, the adipocytokine best characterised as causing insulin resistance is tumour necrosis factor-α (TNF-α), a molecule which under normal circumstances circulates in low concentrations. We propose a vasoregulatory role for local deposits of fat around blood vessels, which may contribute both to insulin action and to vascular endothelial dysfunction. In particular, we propose that the localised fat depot around the origin of skeletal muscle arterioles may play a physiological role in blood flow distribution. Isolated rat arterioles are under dual regulation by insulin, which activates both endothelin-1 mediated vasoconstriction and nitric oxide mediated vasodilatation. In obese rat arterioles, insulin-stimulated nitric oxide synthesis is impaired, resulting in unopposed vasoconstriction. We propose this to be the consequence of production of TNF-α from the fat surrounding the vessel origin - a depot to which we ascribe a specialist vasoregulatory role. We suggest that this cytokine accesses the nutritive vascular tree to inhibit insulin-mediated capillary recruitment - a mechanism we term ‘vasocrine’ signalling. We also suggest a homology between periarteriolar fat and both periarterial and visceral fat, which may, through outside-to-inside signalling, play a direct role in producing the inflammatory changes found in atherosclerotic plaques, so explaining relationships between visceral fat, insulin resistance, and vascular disease.

Key words

obesity - insulin resistance - adipocytokine - tumour necrosis factor-α - endothelium

References

• 1 Reaven GM. Role of insulin resistance in human disease 1988.  Banting Lecture. Diabetes. 1988;  37 1595-1607
• 2 Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: association with obesity, insulin resistance, and endothelial dysfunction.  Arterioscleros Thromb Vasc Biol. 1999;  19 972-978
• 3 Cai D, Yuan M, Frantz DF, Melandez PA, Hansen L, Lee J, Shoelson SE. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.  Nature Medicine. 2005;  11 183-190
• 4 Yang O, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.  Nature. 2005;  436 356-362
• 5 Mohamed-Ali V, Goodrick S, Rawesh A, Katz D, Miles JM, Katz DR, Yudkin JS, Coppack SW. Subcutaneous adipose tissue secretes interleukin-6 but not tumour necrosis factor-α in vivo.  J Clin Endo Metab. 1997;  82 4196-4200
• 6 Baron AD, Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G. Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans.  J Clin Invest. 1995;  96 786-792
• 7 Zhang L, Vincent MA, Richards SM, Clerk LH, Rattigan S, Clark MG, Barrett EJ. Insulin sensitivity of muscle capillary recruitment in vivo.  Diabetes. 2004;  53 447-453
• 8 Yudkin JS, Eringa E, Stehouwer CDA. Vasocrine signalling from perivascular fat - a mechanism linking insulin resistance and vascular disease.  Lancet. 2005;  365 1817-1820
• 9 Mohamed F, Monge JC, Gordon A, Cernacek P, Blais D, Stewart DJ. Lack of role for nitric oxide (NO) in the selective destabilisation of endothelial NO synthase mRNA by tumor necrosis factor-alpha.  Arterioscler Thromb Vasc Biol. 1995;  15 52-57
• 10 Zhang L, Wheatley CM, Richards SM, Barrett EJ, Clark MG, Rattigan S. TNF-alpha acutely inhibits vascular effects of physiological but not high insulin or contraction.  Am J Physiol Endocrinol Metab. 2003;  285 E654-E660
• 11 Hotamisligil GS, Spiegelman BM. Tumor necrosis factor alpha: a key component of the obesity-diabetes link.  Diabetes. 1994;  43 1271-1278
• 12 Mazurek T, Zhang LF, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O’Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y. Human epicardial adipose tissue is a source of inflammatory mediators.  Circulation. 2003;  108 2460-2466
• 13 Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, Di Mario U, Leonetti F. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk.  J Clin Endo Metab. 2003;  88 5163-5168

Correspondence